The Biden administration's much-heralded effort to promote distribution of buprenorphine may not be a game changer in our battle to subdue the opioid crisis. This new campaign resembles yet another social experiment in our national clash with addiction, especially when coupled with so-called harm reduction policies that promote drug abuse.
Continue Reading
